ZA883492B - Flunarizine-containing compositions - Google Patents

Flunarizine-containing compositions

Info

Publication number
ZA883492B
ZA883492B ZA883492A ZA883492A ZA883492B ZA 883492 B ZA883492 B ZA 883492B ZA 883492 A ZA883492 A ZA 883492A ZA 883492 A ZA883492 A ZA 883492A ZA 883492 B ZA883492 B ZA 883492B
Authority
ZA
South Africa
Prior art keywords
flunarizine
containing compositions
alcohol
oil
fatty acid
Prior art date
Application number
ZA883492A
Other languages
English (en)
Inventor
Jean Mesens
Mesens Jean
Achiel Paul Van Peer
Paul Van Peer Achiel
Josef Jan Pieter Heykants
Jan Pieter Heykants Josef
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA883492B publication Critical patent/ZA883492B/xx

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fertilizers (AREA)
ZA883492A 1987-05-18 1988-05-17 Flunarizine-containing compositions ZA883492B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5064487A 1987-05-18 1987-05-18

Publications (1)

Publication Number Publication Date
ZA883492B true ZA883492B (en) 1990-01-31

Family

ID=21966482

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA883492A ZA883492B (en) 1987-05-18 1988-05-17 Flunarizine-containing compositions

Country Status (19)

Country Link
EP (1) EP0292050B1 (xx)
JP (1) JPS63303926A (xx)
KR (1) KR880013559A (xx)
AT (1) ATE69555T1 (xx)
AU (1) AU603895B2 (xx)
DE (1) DE3866281D1 (xx)
DK (1) DK268788A (xx)
ES (1) ES2051827T3 (xx)
FI (1) FI882307A (xx)
GR (1) GR3003482T3 (xx)
HU (1) HU199073B (xx)
IE (1) IE60937B1 (xx)
IL (1) IL86395A (xx)
NO (1) NO882134L (xx)
NZ (1) NZ224497A (xx)
PH (1) PH24425A (xx)
PT (1) PT87496B (xx)
RU (1) RU1829935C (xx)
ZA (1) ZA883492B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002520A1 (en) * 1989-08-17 1991-03-07 Cortecs Limited Pharmaceutical formulations
US5532002A (en) * 1989-08-17 1996-07-02 Cortecs Limited Gelatin pharmaceutical formulations
NZ258044A (en) * 1992-11-27 1995-12-21 Faulding F H & Co Ltd Pharmaceutical composition comprising taxol, solubilising agent, an acid and an organic solvent
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
FR2729307B1 (fr) * 1995-01-18 1997-04-18 Seppic Sa Utilisation d'esters d'acides gras ethoxyles comme composants auto-emulsionnables notamment utiles pour la preparation de produits de traitement phytosanitaires ou de medicaments a usage veterinaire ou humain
RU2216549C2 (ru) * 1997-11-07 2003-11-20 Дайити Фармасьютикал Ко., Лтд. Пиперазин-циклодекстриновый комплекс и лекарственное средство, содержащее указанный комплекс
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
IL160166A0 (en) * 2001-09-10 2004-07-25 Tibotec Pharm Ltd Method for the preparation of hexahydro-furo[2,3-b] furan-3-ol
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
EP2488022B1 (en) 2009-10-16 2018-01-10 Mochida Pharmaceutical Co., Ltd. Compositions
CN104069086A (zh) * 2014-07-22 2014-10-01 周有财 一种盐酸氟桂利嗪组合物胶囊及其制备方法
CN113262207B (zh) * 2020-02-17 2022-06-17 正大青春宝药业有限公司 一种盐酸氟桂利嗪胶囊制剂及其制备方法
CN115381791B (zh) * 2022-09-21 2023-06-16 迪沙药业集团有限公司 一种盐酸氟桂利嗪药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
EP0366156B1 (de) * 1984-01-28 1995-01-11 Roshdy Dr. Ismail Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US5047229A (en) * 1986-12-17 1991-09-10 Miles, Inc. Treatment of cardiovascular and cerebral toxicity using calcium modulators

Also Published As

Publication number Publication date
HUT46851A (en) 1988-12-28
JPS63303926A (ja) 1988-12-12
IL86395A (en) 1992-11-15
NZ224497A (en) 1990-04-26
DK268788A (da) 1988-11-19
PT87496A (pt) 1989-05-31
EP0292050A1 (en) 1988-11-23
NO882134L (no) 1988-11-21
PH24425A (en) 1990-06-25
IL86395A0 (en) 1988-11-15
KR880013559A (ko) 1988-12-21
EP0292050B1 (en) 1991-11-21
DK268788D0 (da) 1988-05-17
IE881477L (en) 1988-11-18
HU199073B (en) 1990-01-29
PT87496B (pt) 1992-09-30
IE60937B1 (en) 1994-09-07
DE3866281D1 (de) 1992-01-02
ES2051827T3 (es) 1994-07-01
NO882134D0 (no) 1988-05-16
ATE69555T1 (de) 1991-12-15
RU1829935C (ru) 1993-07-23
GR3003482T3 (en) 1993-02-17
FI882307A0 (fi) 1988-05-17
AU603895B2 (en) 1990-11-29
AU1613288A (en) 1988-11-24
FI882307A (fi) 1988-11-19

Similar Documents

Publication Publication Date Title
ZA883492B (en) Flunarizine-containing compositions
IL88919A (en) Sulfurized compositions, and additive concentrates and lubricating oils containing same
EP0384547A3 (en) Oxidation-resistant alimentary fatty compositions containing an active oxidation-preventing agent extracted from vegetable tissues
NZ219972A (en) Antimicrobial preservative compositions containing fatty acid derivatives
AU1727892A (en) Fatty acid compositions
IL88920A (en) Mixtures of partial fatty acid esters of polyhydric alcohols and sulfurized compositions,and use as lubricant additives
EP0184942A3 (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
AU3402193A (en) Vegetable fat composition containing H2M and HM2- type triglycerides and chocolate composition containing the same
ES8603240A1 (es) Un metodo para preparar una formulacion ectoparasiticida
EG18772A (en) Arthropodicidal compositions containing several pyrethriodal active ingredient
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
IL57506A0 (en) Surfactant compositions and pesticide formulations containing phosphate esters prepared therewith
MY103337A (en) Stabilised pesticidal composition
HUT49621A (en) Insecticides comprising thionophosphoric acid ester as active ingredient and process for producting the active ingredients
ES8601693A1 (es) Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
JPS6416564A (en) Composition for food additive
GB2247893B (en) Fatty acid salts and esters derived from palm oil,and soap compositions containing same
SG88894G (en) Mixtures of partial fatty acid esters of polyhydric alcohols and sulfurized compositions, and use as lubricant additives.
ES2004454A6 (es) Procedimiento para la preparacion de preparados farmaceuticos con contenido de xilometazolina
IT1211765B (it) Formulazioni idrosolubili di ubidecarenoni,procedimento per la loro preparazione e composizioni cosmetiche che li contengono
SG115693G (en) Fatty acid compositions
ATE189383T1 (de) Schweisshemmende cremezusammensetzungen enthaltend triglycerid gelierungsmittel